Literature DB >> 1311655

Isolation and purification of human biliary vesicles with potent cholesterol-nucleation-promoting activity.

J F Miquel1, A Rigotti, E Rojas, E Brandan, F Nervi.   

Abstract

1. Cholesterol nucleation is a critical step in the formation of cholesterol gallstones. This nucleation takes place after aggregation and fusion of cholesterol-rich biliary vesicles, a process probably modulated by biliary proteins. The present study was conducted to identify specific proteins associated with native cholesterol-rich biliary vesicles and to explore their effect on the cholesterol-nucleation time of supersaturated artificial bile. 2. Hepatic bile was obtained from six patients with cholesterol gallstone disease. Biliary vesicles were isolated by ultracentrifugation and were purified by gel filtration chromatography. A small amount of protein (less than 1% by weight) remained associated with the purified cholesterol-rich biliary vesicles. The electrophoretic profile of these proteins was remarkably similar in all six patients, showing the presence of at least six polypeptides (of molecular mass from 52 to 200 kDa), five of them having carbohydrate residues (except the 52 kDa one). The effect of reconstituted biliary vesicle solutions, containing their specific vesicular proteins, on cholesterol-nucleation time was studied by mixing the vesicle solution with artificial supersaturated bile. A potent cholesterol-pronucleating activity, reflected in a 20-70% reduction in nucleation time, was present in the biliary vesicle solutions compared with control solutions having a similar lipid composition. The pronucleating activity disappeared on heating and was not detected in the micellar fraction containing the major proportion of biliary proteins. 3. These results indicate that cholesterol-rich biliary vesicles containing a unique and defined glycoprotein profile can be isolated and purified from human hepatic bile. The potent cholesterol-pronucleating activity of the biliary vesicles from patients with gallstones was unrelated to their lipid composition or cholesterol content.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311655     DOI: 10.1042/cs0820175

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

1.  Comparative study of changing patterns of concanavalin A-binding proteins in early stage of cholesterol gallstone formation.

Authors:  Y Q Chen; D Cai; Y L Zhang; T F Hua
Journal:  World J Gastroenterol       Date:  1997-12-15       Impact factor: 5.742

2.  Biliary alpha 1-acid glycoprotein concentrations in gallstone-free controls and in patients with multiple or solitary cholesterol gallstones.

Authors:  H Nuutinen; M Abei; J Schwarzendrube; S Ginanni Corradini; R M Walsh; P Kawczak; R T Holzbach
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

3.  Biliary aminopeptidase-N and the cholesterol crystallisation defect in cholelithiasis.

Authors:  L Núñez; L Amigo; G Mingrone; A Rigotti; L Puglielli; A Raddatz; F Pimentel; A V Greco; S González; J Garrido
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

4.  Gallbladder motility and lithogenesis in obese patients during diet-induced weight loss.

Authors:  R Zapata; C Severín; M Manríquez; V Valdivieso
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

5.  Purification and characterization of 33.5 kDa vesicular protein in human bile.

Authors:  Jian-Bin Xiang; Duan Cai; Bao-Jin Ma; Xi-Liang Cha; Li-Ying Wang; Han-Qing Mo; Yan-Ling Zhang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

6.  Dietary fat alters the distribution of cholesterol between vesicles and micelles in hamster bile.

Authors:  B I Cohen; T Mikami; N Ayyad; Y Mikami; E H Mosbach
Journal:  Lipids       Date:  1995-04       Impact factor: 1.880

7.  Comparative proteomic analysis of gallbladder bile proteins related to cholesterol gallstones.

Authors:  Diancai Zhang; Jianbin Xiang; Liying Wang; Zhibin Xu; Lidong Sun; Feng Zhou; Xiliang Zha; Duan Cai
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.